Today’s global reimbursement and pricing environments are rapidly converging with global regulatory paradigms. Therefore, development of innovative life science products is, in and of itself, is not enough to successfully commercialize life science products in any geographic area. tJun17 Life Sciences, LLC works with medical device, diagnostics, biotechnology and specialty pharmaceutical organizations around the globe to facilitate the commercialization of innovative and cost effective healthcare technologies. We support biomedical global market stakeholders in the development and execution of comprehensive and strategically aligned regulatory, reimbursement, and pricing strategies that incorporate new global convergence paradigms. In addition, tJun17 Life Sciences supports its clients globally with the preparation of public and private payer dossiers that incorporate the appropriate cost and/or comparative effectiveness studies as well as health technology assessments.